Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Accumulated Expenses (2017 - 2025)

Nutex Health's Accumulated Expenses history spans 9 years, with the latest figure at $26.8 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 5.24% year-over-year to $26.8 million; the TTM value through Dec 2025 reached $26.8 million, up 5.24%, while the annual FY2025 figure was $26.8 million, 5.24% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $26.8 million at Nutex Health, down from $27.9 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $27.9 million in Q3 2025 and bottomed at $154502.0 in Q4 2021.
  • The 5-year median for Accumulated Expenses is $13.0 million (2023), against an average of $13.3 million.
  • The largest annual shift saw Accumulated Expenses skyrocketed 452.08% in 2021 before it decreased 22.26% in 2022.
  • A 5-year view of Accumulated Expenses shows it stood at $154502.0 in 2021, then increased by 1.77% to $157233.0 in 2022, then skyrocketed by 8139.55% to $13.0 million in 2023, then soared by 96.37% to $25.4 million in 2024, then increased by 5.24% to $26.8 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Accumulated Expenses are $26.8 million (Q4 2025), $27.9 million (Q3 2025), and $27.5 million (Q2 2025).